Financial Services

A key partnership is funding hundreds of activities for military children, providing stability and stress relief during deployment and injury recovery.

The dessert franchise touts record sales and coast-to-coast expansion, signaling a froyo comeback. But a closer look reveals a complex story of high hopes and financial risks.

With survey fraud costing millions, Rep Data appoints a former Kantar CIO and Research Defender's founder to sharpen its tech and product focus.

Global consulting giant Andersen partners with niche firm Scimitar to tackle pharma's biggest challenges, signaling a new model for expertise at scale.

With the strategic hire of development veteran Mitch Friedel, Hilco Global is leveraging its new capital strength to dominate the booming experiential retail market.

The unification of Performive and CloudFirst creates a managed services leader targeting complex enterprise IT with expanded security, DRaaS, and IBM Power solutions.

A new class of painkillers promises the power of opioids with a far lower risk of addiction. Tris Pharma's cebranopadol could reshape pain management.

ITRS's acquisition of French DEM leader IP-Label signals a major move to challenge market giants by creating a holistic observability platform for Europe.

The firm is now recruiting for a Phase 1 trial of HWK-007 and has submitted an IND for HWK-016, targeting tough lung, ovarian, and endometrial cancers.

The cybersecurity firm renewed its multi-million dollar GRC contract with a Fortune 100 client, signaling deep trust and validating its market strategy.

Frontier Airlines appoints decade-long veteran James Dempsey as its new CEO and raises its Q4 earnings outlook, signaling operational resilience.

With multiple clinical trials advancing and a savvy global expansion, RESTEM is poised to challenge the treatment paradigm for autoimmune disorders.

Vuzix wins a CES 2026 Innovation Award for its Ultralite Pro, smart glasses so discreet they look ordinary but pack powerful AI for the enterprise.

Positive early human safety data for its lead drug and new candidates for Rett syndrome and MASH signal a pivotal year for ProQR's Axiomer technology.

A new survey shows no firm recovers from cyberattacks in a day, with downtime lasting weeks. Yet, executive focus on resilience may be dangerously waning.

A new report challenges raid-focused tactics, using survivor stories to offer a blueprint for preventing exploitation in America's illicit massage industry.

The Spanish epigenetics leader will showcase its advanced CNS and oncology pipeline at key January conferences, seeking partners and investor validation.

The pet franchise doubled its stores in 3 years, achieving $150M in sales. Its rapid rise reflects a booming market and a new competitive landscape.

A new alliance between fintech innovators K1x and Juno promises to automate the most dreaded part of tax season, freeing CPAs from manual data entry.

With an expanded Boehringer Ingelheim deal and a new CMO, Enara Bio is set to take its novel 'Dark Antigen' therapy into human trials in 2026.